The Report
Verified funding, headquarters, and leadership news from the world's most innovative businesses
3 reports and counting
Breye Therapeutics Raises €67.5M Series A for Oral Retinal Disease Drugs
Breye Therapeutics raised an over-subscribed €67.5 million Series A co-led by Mission BioCapital and Novo Holdings to advance danegaptide into a Phase 2 trial.
SpyGlass Pharma Opens New Headquarters in Irvine
SpyGlass Pharma opened a 33,000-square-foot headquarters in Irvine, California, on August 27, 2026, moving from its former facility in Aliso Viejo as it prepares for its first product launch.
Aldeyra Therapeutics Headquarters - Office Location & Address
Discover Aldeyra Therapeutics's headquarters at 131 Hartwell Ave, Lexington, MA 02421. Ophthalmology therapeutics developer. Learn about the office facilities and work environment.
Showing 3 reports • Page 1 • Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.